Nasopharyngeal carcinoma, Immune checkpoint inhibitor, Immune-related adverse event, Immunotherapy, Meta-Analysis
Leptomeningeal metastases, Osimertinib resistance, macrophage, Midkine, Cerebrospinal fluid